Skip to main content

Comparative Accuracy of the European Society of Cardiology Rapid Rule-Out and Rule-In Protocols for Diagnosing Non-ST-Segment-Elevation Myocardial Infarction: A Network Meta-Analysis

In brief

Ten troponin assays showed 97.8% to 99.8% sensitivity in 1-hour testing

Across 10 prospective emergency-department studies, European Society of Cardiology 1-hour testing protocols had 97.8% to 99.8% sensitivity and 89.8% to 98.1% specificity across assays. No assay clearly outperformed the others after accounting for imperfect reference tests, so the analysis does not identify a best test; evidence for 2-hour and 3-hour protocols was limited.

Journal
Journal of the American Heart Association (Q1)
Published
18 November 2026
Study design
Systematic review of cohort studies
Evidence level
Level 2, Moderate (CEBM 2a)
Authors
Hirotaka Ohtake, Teruhiko Terasawa, Zhivko Zhelev, Morwenna Rogers, Jaime L Peters, Ingar Z Restan, et al.
PMID
43048779
DOI
10.1161/JAHA.125.047758

Why clinicians should know about it

  • Picked for Emergency Medicine (paper of the day, 21 November 2026): Emergency department troponin algorithms for rapid MI rule-out

Abstract

BACKGROUND: The European Society of Cardiology rapid rule-out and rule-in protocols using hs-cTns (high-sensitivity cardiac troponins) with blood collection at 0 and 1 hour (0/1 hour), 0 and 2 hours (0/2 hours), and 0 and 3 hours (0/3 hours) are accurate and widely used for evaluating non-ST-segment-elevation myocardial infarction. This network meta-analysis aimed to identify the best performing hs-cTn assay. METHODS: We conducted database searches up to January 15, 2026, a dual screening and eligibility assessment, independent data extraction and risk of bias assessment, a network meta-analysis of diagnostic accuracy, and assessment of the certainty of evidence. Only full-paired diagnostic accuracy studies conducted in the emergency department were included. RESULTS: Ten prospective studies (15 publications) comparing 10 assays using the 0-/1-hour algorithm (n=8769), 0-/2-hour algorithm (n=1881), and 0-/3-hour algorithm (n=1236) were included. Comparisons between newer and conventional assays largely stemmed from a single-source study. Across all assays, the European Society of Cardiology 0-/1-hour algorithm demonstrated high sensitivity (summary point estimate range: 97.8%-99.8%). Furthermore, it maintained high specificity (89.8%-98.1%), with no assay showing clear superiority. The summary sensitivity and specificity did not show significant differences across assays after adjusting for biases because of imperfect reference standards. Comparative data in the European Society of Cardiology 0-/2-hour and 0-/3-hour algorithms were limited. CONCLUSIONS: Evidence remains insufficient to establish the superiority of any specific hs-cTn assay within the European Society of Cardiology 0-/1-hour algorithm. Although practical considerations may currently guide selection, continued validation of newer assays remains necessary.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.